Elsevier

Social Science & Medicine

Volume 36, Issue 8, April 1993, Pages 1071-1076
Social Science & Medicine

Property rights and payment to patients for cell lines derived from human tissues: An economic analysis

https://doi.org/10.1016/0277-9536(93)90125-NGet rights and content

Abstract

The increasing potential for commercial applications in biotechnology has given rise to new legal and ethical questions with regard to ownership of human tissue. As the potential value of human cells and tissue has risen, so have donors' calls for a share in the profits. However, in a recent California ruling (John Moore vs the Regents of the University of California), the court once again held to its traditional position that individuals do not hold property rights in their own tissue and cells. We will show that, in the rare case where tissue value may be determined prospectively, a one-time payment (and, hence granting a property right) is efficient. Moore is such a case. In general, however, the transactions costs of granting full property rights to donors of tissue and cells outweigh the benefits of such a change in policy.

References (15)

  • U.S. Congress, Office of Technology Assessment

    New Developments in Biotechnology: Ownership of Human Tissues and Cells—Special Report

    (1987)
  • J. Stone

    Cells for sale

    Discover Mag.

    (1988)
  • P.M. Parker

    Property interests in bodily tissues

    J. legal Med.

    (1989)
  • Office of Technology...
  • R.J. Hay

    Banking and strain data of cell cultures

  • R.J. Hay

    Report to the TCA Executive Board on The American Type Culture Collection

    (13 April 1990)
  • B. Merz

    Whose cells are they, anyway?

    Am. Med. News

    (1990)
There are more references available in the full text version of this article.

Cited by (0)

View full text